Begbies Traynor Group PLC Directorate Change (4840O)
01 Febrero 2023 - 1:00AM
UK Regulatory
TIDMBEG
RNS Number : 4840O
Begbies Traynor Group PLC
01 February 2023
1 February 2023
Begbies Traynor Group plc
Directorate change
Appointment of new independent non-executive director
Begbies Traynor Group plc (the 'company' or the 'group'), the
business recovery, financial advisory and property services
consultancy, announces the appointment of Mandy Donald to the board
as an additional independent non-executive director with immediate
effect; she will also join the board's audit committee.
Mandy is a chartered accountant and experienced non-executive
director. She joined EY in 1992, qualified as a chartered
accountant and spent 10 years working in professional roles in the
firm. In 2002 she was appointed as EY's UK director of finance and
operations and from 2007-2012 was the global director of finance
and operations for EY's transaction advisory services and EY
assurance services.
Since 2012, Mandy has held a number of non-executive director
positions in the financial and professional services sectors
including at Punter Southall, Liontrust Asset Management plc, JP
Morgan Investment Trust plc and Gowling WLG LLP, as well as in the
not for profit sector at the Institute of Cancer Research; these
roles included acting as chair of several audit committee and risk
committees.
Commenting on Mandy's appointment, Ric Traynor, Executive
Chairman said:
"I am delighted that Mandy is joining Begbies Traynor Group's
board; she brings valuable and relevant experience from her
executive and non-executive roles and will complement and broaden
the board's existing skills and expertise. We look forward to
working with her."
Regulatory disclosures
Full name Mandy Donald
Age 50
--------------------------------------------
Shareholding in the Company No shares held
--------------------------------------------
Current directorships and JPMorgan US Smaller Companies Investment
partnerships Trust plc
Liontrust Asset Management plc
Punter Southall Group Limited
Institute of Cancer Research: Royal Cancer
Hospital
--------------------------------------------
Directorships and partnerships Liontrust Multi-Asset Limited
held within the past five
years
--------------------------------------------
Save as set out in this announcement, there are no further
disclosures required under Rule 17 Schedule 2 (g) of the AIM
Rules.
- ENDS -
Enquiries please contact:
Begbies Traynor Group PLC 0161 837 1700
Ric Traynor - Executive Chairman
Nick Taylor - Group Finance Director
Canaccord Genuity Limited 020 7523 8000
(Nominated Adviser and Joint Broker)
Emma Gabriel / Patrick Dolaghan
Shore Capital 020 7408 4090
(Joint Broker)
Malachy McEntyre / Mark Percy / Anita Ghanekar / James
Thomas
MHP Communications 020 3128 8567
Reg Hoare / Katie Hunt / Pauline Guenot begbies@mhpc.com
Further information on Begbies Traynor Group can be accessed via
the Group's website at
www.begbies-traynorgroup.com/investor-relations
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOASDSFWFEDSEIF
(END) Dow Jones Newswires
February 01, 2023 02:00 ET (07:00 GMT)
Begbies Traynor (AQSE:BEG.GB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Begbies Traynor (AQSE:BEG.GB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
